All diseases

Disease Atlas / Disease detail

Osteogenesis imperfecta

An atlas of genetically heterogeneous bone fragility, broad clinical spectrum, molecular diagnosis, fracture prevention, and multidisciplinary care.

osteogenesis imperfecta · OI · brittle bone disease

MONDO:0019019Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · 1822baabb255

Disease class
OI is a group of genetic bone-fragility disorders.
Core mechanism
COL1A1 and COL1A2 variants are common causes.
Genes or cause
Other genes cause recessive or X-linked OI.
Typical features
Severity ranges from mild fractures to perinatal lethality.
Variability
Short stature, deformity, and scoliosis can occur.
Diagnosis
Hearing, teeth, eyes, and breathing can be affected.
Management
Diagnosis integrates clinical, imaging, family, and molecular findings.
Treatment and research
Bone density alone cannot establish diagnosis.
Reading evidence
Safe exercise and rehabilitation support function and bone health.
Key caution
Fractures are treated with alignment and growth in mind.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a glance

OI is a group of genetic bone-fragility disorders.

Severity ranges from mild fractures to perinatal lethality.

How the disease works

COL1A1 and COL1A2 variants are common causes.

Other genes cause recessive or X-linked OI.

Why experiences vary

Short stature, deformity, and scoliosis can occur.

Diagnosis and management

Hearing, teeth, eyes, and breathing can be affected.

Treatment status

Diagnosis integrates clinical, imaging, family, and molecular findings.

Bone density alone cannot establish diagnosis.

Reading clinical trials

Orthopedic, dental, hearing, and respiratory health are monitored lifelong.

Topics for a clinical visit

Fracture history, genotype, function, and pain require review.

Medical notice

This material is for disease education and is not a personal diagnosis or treatment instruction.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.